F. Magne

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Nancy E. Marion, B. Delclaux, B. Asselain, 2022, The Lancet regional health. Europe.

A formalized transition program for cystic fibrosis: A 10‐year retrospective analysis of 97 patients in Lyon

P. Reix, I. Durieu, Q. Reynaud, 2021, Pediatric pulmonology.

Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry

A. Drilon, M. Okada, S. Ou, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NRG1 fusion-positive lung cancers: Clinicopathologic profile and treatment outcomes from a global multicenter registry.

A. Drilon, J. Shih, R. Doebele, 2019, Journal of Clinical Oncology.

NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry

A. Drilon, J. Shih, R. Doebele, 2019, Lung cancer.

[Effects of fine particulate matter from on bronchial epithelial cells].

R. Aloui, Gilles Devouassoux, P. Ritter, 2016, Revue des maladies respiratoires.